Recent case-control and cross-sectional studies reveal a significant statistical link between low serum 25-hydroxyvitamin D concentrations and acute coronary syndrome. Researchers note that patients presenting with cardiovascular events frequently exhibit severe or mild-to-moderate vitamin D deficiencies, though clinical trials have yet to confirm a definitive causal relationship.
Investigating Vitamin D Status in Acute Coronary Syndrome Cases
Medical researchers have increasingly turned their attention toward non-traditional biomarkers like vitamin D to better understand cardiovascular risk and disease pathogenesis. A hospital-based case-control study conducted at the medical wards and intensive care unit of NKP Salve Institute of Medical Sciences & Research Center and Lata Mangeshkar Hospital in Nagpur, India, examined the relationship between serum 25-hydroxyvitamin D concentrations and acute coronary syndrome over a two-year period from January 2021 to December 2022.
The investigation included 140 participants divided evenly into 70 patients presenting with acute coronary syndrome—encompassing ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, and unstable angina—and 70 age- and sex-matched controls without the condition. Using a chemiluminescent immunoassay to measure serum 25-hydroxyvitamin D, investigators categorized levels into severe deficiency below 10 ng/mL, mild-to-moderate deficiency ranging from 10.0 to 19.9 ng/mL, insufficiency between 20.0 and 29.9 ng/mL, and sufficiency at 30 ng/mL or higher. Following multivariable logistic regression analysis adjusted for age and sex, participants with concentrations below 30 ng/mL demonstrated significantly higher odds of acute coronary syndrome compared to those with sufficient levels.
A separate evaluation yielded comparable baseline findings. Researchers analyzed 60 acute coronary syndrome patients hospitalized at the cardiology department of Dr. Josip Benčević General Hospital between March 2012 and October 2012 alongside 60 age- and sex-matched controls according to published data from the School of Medicine at Josip Juraj Strossmayer University. The study recorded a statistically significant difference in mean serum concentrations, with patients with acute coronary syndrome showing a lower mean 25-hydroxyvitamin D level of 35.19 nmol/L compared to 58.08 nmol/L in the control group.
Biological Mechanisms Linking Vitamin D to Vascular Health
The physiological rationale for connecting vitamin D to cardiac events centers on its broad distribution throughout the cardiovascular system. Receptors for the vitamin reside directly within vascular endothelial cells, vascular smooth muscle cells, and cardiomyocytes. Experimental models indicate that active vitamin D helps regulate the renin-angiotensin-aldosterone system, influences inflammatory pathways, and supports vascular integrity.
Deficiencies can disrupt these protective mechanisms, potentially promoting endothelial dysfunction, arterial stiffness, and a prothrombotic state.
Beyond acute coronary events, population-wide surveys have explored broader vascular implications. Data from the National Health and Nutrition Examination Survey spanning 2001 through 2004, conducted by the National Center for Health Statistics, evaluated nationally representative samples of U.S. adults aged 40 and older to assess serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease. These extensive health surveys incorporated standardized physical examinations, mobile examination center blood draws, and ankle-brachial index measurements to chart how non-traditional risk factors intersect with vascular disease.
Evaluating Prognostic Value and Clinical Limitations
Despite the consistent observation of low vitamin D levels among cardiac patients, determining whether supplementation improves long-term outcomes remains complex. In the hospital cohort, researchers tracked acute coronary syndrome patients across a 36-month period to observe major adverse cardiac events. While patients who subsequently suffered events exhibited low initial vitamin D levels, the variance compared to event-free survivors did not achieve statistical significance during the three-year follow-up.
Subgroup analyses also revealed intersecting metabolic vulnerabilities. The lowest mean vitamin D concentrations surfaced consistently among patients presenting with both acute coronary syndrome and diabetes mellitus. In the Nagpur case-control study, investigators likewise found that while severe and mild-to-moderate deficiencies were highly prevalent among cases, serum status did not demonstrate a significant association with the angiographic extent of underlying coronary artery disease.
While retrospective and case-control studies establish a clear statistical correlation between hypovitaminosis D and ischemic events, researchers caution that observational designs cannot establish definitive causality. Definitive resolution on whether targeted vitamin D repletion actively alters cardiovascular trajectories requires larger, prospective clinical trials.
Worth a look
